Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Influence of infection on exacerbations of multiple sclerosis.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
World Congress of Neurology (WCN) 2015
The use of hematopoietic stem cells in autoimmune diseases.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
The endocannabinoid system and multiple sclerosis.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Overview of the immune system.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
MicroRNAs: The Role in Autoimmune Inflammation.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.

Pages